← Leaderboards
Ravi Srinivasan
Onconano Medicine, Inc.
$1,821,005
Attributed
$1,821,005
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $840.9K · FY2017–20$1M$750K$500K$250K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$1,821,005 · 1
By mechanism
R44$1,821,005 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Disseminated Malignant Neoplasm”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Jennifer Marie Suga · Kaiser Foundation Research Institute$17,245,643
- Bronwen Shaw · Medical College Of Wisconsin$10,328,749
- Andrew Counts · National Cancer Institute$8,441,713
- Emily Van Meter Dressler · Wake Forest University Health Sciences$6,111,354
- Kathleen N. Moore · University Of Oklahoma$6,075,883
Research focus
Disseminated Malignant NeoplasmAcidityAcidosisBaseBehaviorAdme StudyBloodAnalogCancer ImagingCancer SurgeryCanis FamiliarisChemotherapyClinical ImagingClinical TranslationCoagulation ProcessContrast ImagingCoupledCancer BiomarkersDecision MakingDetectionDiagnosticDi-Block CopolymerDigitalDose
Grant awards (5)
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors$790
R44 · FY2020 · CA · contact PI
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors$836,546
R44 · FY2019 · CA · contact PI
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors$4,318
R44 · FY2019 · CA · contact PI
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors$710,496
R44 · FY2018 · CA · contact PI
Novel Fluorescent Diagnostic Agents for Detection, Staging, andIntraoperative Imaging of Tumors$268,855
R44 · FY2017 · CA · contact PI